Cargando…
Comprehensive review of reports of menstrual irregularities associated with isotretinoin
In 1982, oral isotretinoin was first licensed as a treatment option for severe recalcitrant cystic acne in the United States. Since its introduction into the pharmaceutical market, several instances of amenorrhea in women of child-bearing age taking isotretinoin have been reported. In each documente...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060655/ https://www.ncbi.nlm.nih.gov/pubmed/33898699 http://dx.doi.org/10.1016/j.ijwd.2020.07.004 |